Bacteria engineered to secrete rheumatoid arthritis drug in the body
Instead of injections or pills, why not engineer bacteria to secrete therapeutic molecules from within our gut? A new study is demonstrating this futuristic idea, showing how a genetically modified probiotic can produce an experimental anti-inflammatory molecule and effectively treat rheumatoid arthritis in rats."People don't like to have injections for the rest of their lives," said co-corresponding author Christine Beeton, from the Baylor College of Medicine. "In the current work, we explored the possibility of using…